Follicle-stimulating hormone (FSH), a glycoprotein secreted by gonadotroph cells of the anterior pituitary, is classically ...
Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...
Over the past two decades there have been tremendous advancements in the understanding of both the prevalence and the ...
Amid accelerating advances in artificial intelligence, the UK risks neglecting the biological foundations of natural ...
Endogenous Cushing's syndrome is a severe, potentially lethal, endocrine condition. It is well known for its pleomorphic ...
The Lancet Commission on rethinking coronary artery disease1 offers important advances in cardiovascular disease (CVD) prevention. The Commission argues, correctly in our opinion, that identification ...
The integration of Bruton tyrosine kinase (BTK) inhibitors into first-line treatment regimens, in combination with ...
The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from ...
FACT: #COVID19 is NOT airborne”, declared a tweet from WHO in March, 2020. WHO did not officially accept until almost 2 years ...
The recent ceasefire agreement is bringing a fragile peace to Gaza. Aside from a cessation of hostilities, it has important ...
As the US foreign assistance architecture faces unprecedented dismantling, lessons from past crises take on urgent significance. Our new analysis of COVID-19 donor funding1 reveals a profound ...
In the REC-CAGEFREE I trial by Chao Gao and colleagues,1 an open-label, randomised, non-inferiority trial comparing a drug-coated balloon (DCB) with a drug-eluting stent (DES) in patients with de novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback